2011-08-15T15:36:43-05:00 2010-09-30 LARSONALLEN LLP 2900 SOUTH QUINCY ST SUITE 150 ARLINGTON VA 22206 990 2009-10-01 522059102 National Blood Foundation Research and Education Trust Fund NATI 3019076977 8101 Glenbrook Road Bethesda MD 20814 MARK R CONHEADY 3019076977 2011-08-15 1 7039985100 2009 2016-02-24 21:20:13Z karen shoos lipton 8101 Glenbrook Road Bethesda MD 20814 4260573 0 X www.aabb.org X 1997 MD TO FUND BLOOD RESEARCH AND EDUCATION. 8 8 0 9 0 0 1009744 928800 0 -342050 382683 26725 4358 694419 1315841 522285 599750 0 0 0 92932 253151 241568 775436 841318 -81017 474523 7287446 7981596 16018 7287446 7965578 To advance, through scientific research, the practice and standards of transfusion medicine and cellular and related biological therapies. 0 0 666151 599750 EIGHT GRANTS WERE AWARDED TO EIGHT PRINCIPAL INVESTIGATORS AT EIGHT INSTITUTIONS. SIX WERE AWARDED FOR BLOOD TRANSFUSION RESEARCH AND TWO WERE AWARDED FOR CELLULAR THERAPY RESEARCH. THE RESEARCH FINDINGS ARE PUBLISHED BY American Association of Blood Banks AND OTHER BLOOD TRANSFUSION AND SCIENTIFIC JOURNALS AND PERIODICALS. 666151 1 1 0 0 0 0 0 0 1 1 1 0 0 0 1 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 8 8 0 0 0 0 0 0 0 1 0 0 0 1 1 1 1 1 1 0 0 0 X Mark Conheady 2403336615 8101 Glenbrook RD BETHESDA MD 20814 X Greg Sunset 1.00 X X 0 0 0 Jack mcGuire MBA 1.00 X 0 0 0 Susan Roseff MD 1.00 X 0 0 0 Dale Malloy DPA 1.00 X 0 0 0 Tom Graham MBA 1.00 X 0 0 0 Robert jones mba 1.00 X 0 0 0 NORA HIRSCHLER MD 1.00 X 0 0 0 J DANIEL CONNOR MBA 1.00 X 0 0 0 Karen Shoos Lipton JD 2.00 X 0 335501 34777 mark conheady 2.00 X 0 152616 7428 0 488117 42205 0 0 1 0 0 928800 928800 140366 140366 3187049 2944732 242317 242317 242317 4358 4358 4358 1315841 4358 0 382683 524750 524750 75000 75000 154886 46466 15488 92932 19585 19585 47070 47070 AWARD FEES 19935 19935 BANK CHARGES 92 92 841318 666151 82235 92932 126228 248205 957585 666681 271391 5301001 6433359 631241 633351 7287446 7981596 16018 0 16018 X 6254979 6888002 442243 480925 590224 596651 7287446 7965578 7287446 7981596 X 0 1 1 X 0 X X X 0 0 0 Amer Assoc Blood Banks 362384118 7 1 1 1 0 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 656633 3990 53204 24702 689125 643529 25 26355 13276 656633 0.86580 0.13850 0 0 0 Securities not publicly traded 633351 F 633351 1315841 841318 474523 203609 203609 678132 1268771 0 1268771 47070 47070 1315841 794248 0 794248 47070 47070 841318 Part V, Line 4: Description of Intended Use of Endowment Funds: Permanently Restricted net assets Represents contributions received for the Hemphill-Jordan Leadership Award, the Emily Cooley Memorial Award and Lectureship, the Tibor Greenwalt Memorial Award and Lectureship, and a contribution made by the estate of Bernice Hemphill. The earnings from the Hemphill-Jordan contributions are temporarily restricted for the purpose of honoring leaders from the blood banking and transfusion medicine community who have made significant contributions in the areas of administration, quality programs, law, and/or government affairs. The earnings from the Emily Cooley contribution are temporarily restricted for the purpose of honoring an individual who has demonstrated teaching ability and has made a major contribution to the field of immunohematology and transfusion medicine or cellular therapies. The earnings on the Tibor Greenwalt contribution are to be added to the endowment until the total endowment reaches $100,000, at which time any future earnings will be temporarily restricted for the purpose of the award and lectureship honoring an individual who has made major scientific or clinical contributions to hematology and transfusion medicine. The earnings from the Bernice Hemphill estate contribution are temporarily restricted for the purpose of establishing a blood-banking museum at the national headquarters. Part X: Description of Uncertain Tax Positions Under FIN 48: THe Trust has adopted the income tax standard for uncertain income tax positions. The Trust has evaluated its tax positions and determined that they are more-likely-than-not to be sustained on examination. The Trust's income tax returns are subject to review and examination by federal and state authorities. The Trust is not aware of any activities that would jeopardize its tax-exempt status. The Trust is not aware of any activities that are subject to tax on unrelated business income or excise or other taxes. The tax returns for the fiscal years ended 2007 through 2009 are open to examination by federal and state authorities. 1 north america grantmaking grant awarded for blood transfusion research 75000 0 0 75000 Scientific Research grant north america 1 75000 CHECK N/A N/A Procedure for Monitoring Grants Outside the U.S.: Schedule F, Part I, Line 2: AN APPLICANT MUST BE A DOCTOR (MD OR PHD), MEDICAL TECHNOLOGIST, OR TRANFUSION MEDICINE PROFESSIONAL. ALL APPLICANTS ARE CONSIDERED REGARDLESS OF AGE, RACE, GENDER, NATIONAL ORIGIN, OR RELIGION. EMPHASIS WILL BE GIVEN TO FIRST TIME APPLICANTS WHO HAVE SUBMITTED A STRONG PROGRESS REPORT. PRIORITY IN AWARDING GRANTS WILL BE GIVEN TO INNOVATIVE AND/OR NEW PROJECTS. AT NO TIME WILL AN APPLICATION BE CONSIDERED AFTER HAVING BEEN SUBMITTED THREE TIMES. GRANTS WILL NOT BE GIVEN TO ANY ONE INVESTIGATOR MORE THAN TWICE. AWARDS WILL NOT BE MADE TO INCREASE THE FUNDING AVAILABLE FOR CURRENTLY FUNDED RESEARCH PROJECTS. THESE GRANTS ARE INTENDED TO PROVIDE "SEED"-TYPE FUNDING THAT ALLOWS THE PRINCIPAL INVESTIGATOR TO ENHANCE PRELIMINARY DATA. THIS DATA MAY THEN BE USEFUL IN APPLYING FOR LARGER GRANTS. GRANT RECIPIENTS ARE REQUIRED TO PROVIDE A FINAL REPORT ON THE RESEARCH AND UTILIZATION OF FUNDING WITHIN 60 DAYS OF THE END OF THE FUNDING PERIOD. GRANT TERMS MAY BE FOR ONE OR TWO YEARS, WITH A MAXIMUM TOTAL AWARD PER GRANT LIMITED TO $75,000 TO BE USED EXCLUSIVELY FOR RESEARCH. GRANTS AWARDED MAY NOT COVER COSTS SUCH AS TRAVEL OR PUBLICATION FEES. EQUIPMENT EXPENDITURES MAY NOT EXCEED $8,000 PER GRANT. NO AMOUNT OF THE AWARD MAY BE USED FOR INSTITUTIONAL OVERHEAD. ALL DOCUMENTS MUST BE SUBMITTED IN ENGLISH. ALL GRANT APPLICATIONS ARE REVIEWED BY THE NBF GRANTS REVIEW COMMITTEE (GRC). THIS COMMITTEE MEETS ONCE A YEAR TO SELECT AWARD RECEIPIENTS. OUTSIDE REVIEWERS MAY BE CONSULTED AT THE DISCRETION OF THE COMMITTEE. THE NBF BOARD OF TRUSTEES MUST APPROVE AND THE ORGANIZATION (NBFRET) MUST ACCEPT THE GRC'S RECOMMENDATIONS BEFORE OFFICIAL AWARDS CAN BE MADE. APPLIANTS ARE JUDGED ON THE ABILITY TO MEET ELIGIBILITY CRITERIA, SCIENTIFIC MERIT, RELEVANCE TO AND IMPACT ON TRANFUSION SCIENCE, FOCUS AND APPROPRIATENESS TO THE SCOPE OF FUNDING, LIKELIHOOD OF MEANINGFUL DATA, AND LIKELIHOOD OF FUTURE FUNDING POTENTIAL. 1 0 SCIENTIFIC RESEARCH GRANTs 7 524750 0 Procedure for Monitoring Grants in the U.S.: Part I, Line 2: Schedule I, Part I, Line 2: AN APPLICANT MUST BE A DOCTOR (MD OR PHD), MEDICAL TECHNOLOGIST, OR TRANFUSION MEDICINE PROFESSIONAL. ALL APPLICANTS ARE CONSIDERED REGARDLESS OF AGE, RACE, GENDER, NATIONAL ORIGIN, OR RELIGION. EMPHASIS WILL BE GIVEN TO FIRST TIME APPLICANTS WHO HAVE SUBMITTED A STRONG PROGRESS REPORT. PRIORITY IN AWARDING GRANTS WILL BE GIVEN TO INNOVATIVE AND/OR NEW PROJECTS. AT NO TIME WILL AN APPLICATION BE CONSIDERED AFTER HAVING BEEN SUBMITTED THREE TIMES. GRANTS WILL NOT BE GIVEN TO ANY ONE INVESTIGATOR MORE THAN TWICE. AWARDS WILL NOT BE MADE TO INCREASE THE FUNDING AVAILABLE FOR CURRENTLY FUNDED RESEARCH PROJECTS. THESE GRANTS ARE INTENDED TO PROVIDE "SEED"-TYPE FUNDING THAT ALLOWS THE PRINCIPAL INVESTIGATOR TO ENHANCE PRELIMINARY DATA. THIS DATA MAY THEN BE USEFUL IN APPLYING FOR LARGER GRANTS. GRANT RECIPIENTS ARE REQUIRED TO PROVIDE A FINAL REPORT ON THE RESEARCH AND UTILIZATION OF FUNDING WITHIN 60 DAYS OF THE END OF THE FUNDING PERIOD. GRANT TERMS MAY BE FOR ONE OR TWO YEARS, WITH A MAXIMUM TOTAL AWARD PER GRANT LIMITED TO $75,000 TO BE USED EXCLUSIVELY FOR RESEARCH. GRANTS AWARDED MAY NOT COVER COSTS SUCH AS TRAVEL OR PUBLICATION FEES. EQUIPMENT EXPENDITURES MAY NOT EXCEED $8,000 PER GRANT. NO AMOUNT OF THE AWARD MAY BE USED FOR INSTITUTIONAL OVERHEAD. ALL DOCUMENTS MUST BE SUBMITTED IN ENGLISH. ALL GRANT APPLICATIONS ARE REVIEWED BY THE NBF GRANTS REVIEW COMMITTEE (GRC). THIS COMMITTEE MEETS ONCE A YEAR TO SELECT AWARD RECEIPIENTS. OUTSIDE REVIEWERS MAY BE CONSULTED AT THE DISCRETION OF THE COMMITTEE. THE NBF BOARD OF TRUSTEES MUST APPROVE AND THE ORGANIZATION (NBFRET) MUST ACCEPT THE GRC'S RECOMMENDATIONS BEFORE OFFICIAL AWARDS CAN BE MADE. APPLIANTS ARE JUDGED ON THE ABILITY TO MEET ELIGIBILITY CRITERIA, SCIENTIFIC MERIT, RELEVANCE TO AND IMPACT ON TRANFUSION SCIENCE, FOCUS AND APPROPRIATENESS TO THE SCOPE OF FUNDING, LIKELIHOOD OF MEANINGFUL DATA, AND LIKELIHOOD OF FUTURE FUNDING POTENTIAL. 0 0 0 0 0 0 0 0 0 Karen Shoos Lipton JD 0 335501 0 0 0 0 0 19584 0 15193 0 370278 0 0 mark conheady 0 152616 0 0 0 0 0 0 0 7428 0 160044 0 0 Supplemental Information Part III pART i, Line 3: The CEO receives no compensation from National Blood Foundation Research and Education Trust (NBFRET). The CEO receives compensation from NBFRET's related organization, American Association of Blood Banks (AABB). AABB's procedure for determining the compensation of the CEO is: at least every two years, a compensation and benefits specialist reviews all job and job descriptions and ensures that the salary range for each job is competitive with market conditions. AABB's human resources committee annually reviewS tHE Compensation of officers and key employees. The process was last undertaken in February 2010 for the CEO. Form 990, Part VI, Section A, line 8b The organization does not have any committees with authority to act on behalf of the governing body. Form 990, Part VI, Section B, line 11 Copies are sent to the Board followed by a period for comment. Form 990, Part VI, Section B, line 12c All conflict of interest forms are filled out annually. Twice a year at the board meetings, there is a policy to ask that anyone with a perceived conflict of interest abstain from voting and in some cases, they are asked to leave the room. Part VI, Line 15: There are no paid officers or key employees at the organization. Form 990, Part VI, Section C, line 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE THROUGH THE AMERICAN ASSOCIATION OF BLOOD BANKS' WEBSITE (WWW.AABB.ORG). Form 990, part vii The estimated average hours per week devoted to American Association of Blood Banks (AABB), a related organization of National Blood Foundation Research and Education Trust (NBFRET), by Susan Roseff, MD, AND j. DANIEL CONNOR, MBA, RESPECTIVELY, is 10. The estimated average hours per week devoted to AABB by Karen Shoos Lipton, JD, and Mark Royal Conheady, RESPECTIVELY, is 37.5. FORM 990, PART XI, LINE 2C The process has not changed from the prior year. American Association of Blood Banks 8101 GLENDBROOK ROAD BETHESDA MD 20814 362384118 Patient Safety MD 501(C)(3) 7 N/A 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 1